Paul Bremmer

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Oligodeoxynucleotides (ODNs) labelled with an appropriate radionuclide could provide a means to identify serious diseases early on and thereby help initiate treatment at a very early phase. Regardless of important issues like in-vivo stability and membrane passage, the key issue for the oligonucleotide approach is the ability of the radiolabelled ODN to(More)
  • 1